Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Heterogeneous treatment effect estimation using instrumental variable in time-to-event data | Uri Shalit | Technion - Israel Institute of Technology | HIPB | May 13, 2024 | HIPB-13 |
| HFHS Electronic Medical Records compared to HFHS PLCO data | Melody Eide | Henry Ford Health System | PLCO | Sep 9, 2014 | PLCO-105 |
| Higher dietary anthocyanidins is associated with reduced risk of biliary cancer in the PLCO Cancer Screening Trial | Ling Xiang | Department of Clinical Nutrition, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. | PLCO | Jun 22, 2023 | PLCO-1257 |
| High Performance Computing Enabled Deep Learning for Lung Cancer Classification | Derek Ni | F. Hoffmann-La Roche AG | NLST | Jun 8, 2017 | NLST-312 |
| Hispanic Recruitment for the PLCO Screening Trial | Eduard Gamito | University of Colorado | PLCO | Jul 1, 2006 | 2006-0249 |
| Histopathologic Image-based Deep Learning Classifier for Predicting Clinical Outcomes in Cancers | Eunhyang Park | Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea | PLCO | Sep 5, 2023 | PLCOI-1315 |
| History of lethal prostate cancer in the screening arm of PLCO | Jonathan Shoag | NA | PLCO | Aug 7, 2015 | PLCO-147 |
| History of Participants with Lung Cancer who Never Smoked | William Hocking | Marshfield Clinic | PLCO | Jul 1, 2006 | 2006-0192 |
| HMO Data Validation Pilot Study | Paul Pinsky | NCI, DCP, EDRG | PLCO | Jul 1, 2006 | 2006-0215 |
| Homologous recombination repair capacity and breast cancer risk: a nested case control study | Hua Zhao | Virginia Commonwealth University | PLCO | Oct 6, 2022 | 2021-1005 |
| Hormonal factors and risk of lung cancer: Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and a meta-analysis of 10 cohort studies | Zuo-Feng Zhang | Fielding School of Public Health, University of California, Los Angeles, CA, USA | PLCO | Oct 11, 2018 | PLCO-406 |
| Hormonal factors and the risk of breast, endometrial, and ovarian cancers among nulliparous women | Sara Schonfeld | NCI, DCEG, REB | PLCO | Feb 15, 2008 | 2007-0064 |
| Hormone Replacement Therapy and Risk of Endometrial Cancer: Results from a Prospective cohort study | Hao Liu | Guangdong Food and Drug Vocational College, Guangzhou, Guangdong, China | PLCO | Feb 17, 2021 | PLCO-734 |
| Hormone replacement therapy use and risk of breast cancer incidence and death | Yi Jiang | Department of General Medicine and Geriatrics ,Chongqing University Central Hospital ,Chongqing Emergency Medical Center, China, 400000 | PLCO | Nov 19, 2020 | PLCO-694 |
| Hospital Mortality prediction | Khoi Pham | CSUSB | NLST | May 11, 2015 | NLST-138 |
| How does vitamin E supplementation protect against clinically relevant prostate cancer in smokers? A molecular epidemiologic study in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screeni | Demetrius Albanes | NCI, DCEG, NEB | PLCO | May 7, 2007 | 2007-0007 |
| How effective is PSA Screening as a mode of prevention for Prostate Cancer in Men over the age of 50? | Jiana Karthikeyan | Franconian International School | PLCO | Apr 29, 2024 | PLCO-1543 |
| HSD17B1 Genetics | Richard Hayes | NCI, DCEG, OEEB | PLCO | Jul 1, 2006 | 2006-0134 |
| HSQ Validation Study | Lisa Gren | University of Utah | PLCO | Jul 1, 2006 | 2006-0310 |
| Identification and characterization of common genetic variants associated with circulating CA-125 | Hannah Yang | NCI, DCEG, HREB | PLCO | Jul 1, 2010 | 2010-0092 |